Table 1.
Publication | Disease | Gene/SNP | Cell Type | Assays | Treatment | Main findings |
---|---|---|---|---|---|---|
Lieberman et al., 2012 | Alcohol Use Disorder | – | Mixed population forebrain lineage neurons and astrocytes |
|
Acute and 7-day alcohol exposure |
|
Lieberman et al., 2015 | Alcohol Use Disorder |
GABRA2 (rs279858*C) |
Mixed population forebrain lineage neurons and astrocytes |
|
– |
|
De Filippis et al., 2016 | Alcohol Use Disorder | – | NPCs |
|
Chronic alcohol exposure |
|
Lieberman et al., 2018 | Alcohol Use Disorder | – | Forebrain-type excitatory glutamate neurons |
|
21 day alcohol exposure |
|
Oni et al 2015 | Nicotine Dependence |
CHRNA5 (rs16969968) |
Dopaminergic and glutamatergic neurons |
|
Acute nicotine |
|
Deflorio et al., 2017 | Nicotine Dependence |
CHRNA5 (rs16969968) |
Dopaminergic neurons |
|
Acute nicotine & Acetylcholine |
|
Mertens et al., 2015b | Bipolar Disorder | – | Hippocampal DF-like neurons |
|
Lithium |
|
Stern et al., 2017 | Bipolar Disorder | – | Hippocampal DG-like neurons |
|
Lithium |
|
Brennand et al., 2011 | Schizophrenia | – | Mixed population of forebrain lineage neurons |
|
Loxapine |
|
Toyoshima et al., 2016 | Schizophrenia | 22q11.2; DCGR8 | Forebrain-like neurospheres |
|
– |
|
Lin et al., 2016 | Schizophrenia | 22q11.2 | Mixed population of glutamatergic and GABAergic neurons |
|
– |
|
Liao et al., 2016 | Alzheimer’s Disease | APP | Mixed population forebrain lineage neurons |
|
– |
|
Raja et al., 2016 | Alzheimer’s Disease | APP; PSEN1 | Cortical organoids |
|
β and γ secretase inhibitors |
|
Huang et al., 2017 | Alzheimer’s Disease | APOE | Mixed population forebrain lineage neurons |
|
suppression of gene expression with CRISPR |
|
Wang et al. 2018 | Alzheimer’s Disease | APOE |
|
|
|
|